Isatuximab plus Iberdomide maintenance helps MRD-positive myeloma patients turn MRD-negative after transplant, with manageable safety.
|Articles|April 18, 2022
Daily OTC Pearl: Wal-itin Loratadine Tablets
Author(s)Saro Arakelians, PharmD
Loratadine is an antihistamine that treats symptoms of allergies such as itching, runny nose, watery eyes, and sneezing.
Advertisement
OTC/Lifestyle Pearl of the Day: Wal-itin Loratadine Tablets
Indication: Loratadine is a 24-hour antihistamine that treats symptoms of allergies such as itching, runny nose, watery eyes, and sneezing.
Insight:
- Non-drowsy allergy medication.
- Works for indoor and outdoor allergies.
- Ingredients: loratadine 10 mg.
- Classified as an antihistamine.
- It comes in a tablet format.
- Provides 24 hours coverage with 1 tablet to relieve allergy symptoms.
- Take as directed and not for children.
Source:
Advertisement
Related to this article
Insulin efsitora alfa-gobe (Onswik; Eli Lilly) is designed to deliver steady basal insulin levels over a full 7-day duration.
Vallerie McLaughlin, MD, explains why the ERS update strongly recommends sotatercept for patients with pulmonary arterial hypertension (PAH) who don't reach low-risk status on initial therapy.
Imaging data from the CONTENTed study suggest the type 2 inflammation that drives severe asthma may affect more than the airways.
Renal benefit appeared only in patients with albuminuria in a 75,455-person BMJ analysis, whereas sulfonylureas signaled faster decline without it.
Authors of a pharmacist-directed transitions-of-care study discuss what drives pneumococcal vaccine hesitancy and how pharmacists can build systematic vaccine screening into inpatient workflows.
HYPERION trial data now support sotatercept within a patient's first year of pulmonary arterial hypertension (PAH) diagnosis, cutting clinical worsening risk by 76% compared with placebo.
A stewardship program combining EHR alerts and pharmacist-led education offers a replicable model for reducing bleeding risk.
Advertisement
Advertisement
Trending on Pharmacy Times
1
After 180 Years, Multiple Myeloma Gets a Definition of Cure
2
Severe Asthma's Effects May Extend Beyond the Lungs, Brain Imaging Study Suggests
3
Alcohol and GLP-1 Therapy: Key Counseling Points for Pharmacists
4
Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps
5